REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

12 Apr 2022 08:31

RNS Number : 0991I
Liberum Capital Limited
12 April 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sensyne Health PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Sensyne Health PLC

(d) Date dealing undertaken:

11th April 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 10p

 

Purchase

 

 

98,129

 

0.019

 

0.019

 

ORD 10p

 

Sale

 

 

184,619

 

0.021

 

0.02

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

12th April 2022

 

Contact name:

Rajvinder Mahil

Telephone number:

020 3100 2213

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGRGDSCDBDGDD
Date   Source Headline
7th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
6th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
6th Apr 20229:51 amRNSForm 8.5 (EPT/RI)
5th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
5th Apr 20228:44 amRNSForm 8.5 (EPT/RI)
5th Apr 20228:03 amRNSForm 8.3 - Sensyne Health Plc
5th Apr 20227:00 amRNSRule 2.9 Announcement
4th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
4th Apr 20229:01 amRNSForm 8.5 (EPT/RI)
4th Apr 20227:00 amRNSIssue of New Ordinary Shares & Total Voting Rights
1st Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
31st Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
30th Mar 20229:34 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
29th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
28th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
28th Mar 20227:00 amRNSChange in Registered Office
25th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
24th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
23rd Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
22nd Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
21st Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
21st Mar 20227:00 amRNSRule 2.9 Announcement
18th Mar 20227:00 amRNSIssue of New Ordinary Shares to GOSH
17th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
16th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
15th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
14th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Mar 20228:14 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
10th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
9th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc replacement
9th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Mar 20228:53 amRNSForm 8.5 (EPT/RI)
7th Mar 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
7th Mar 20228:39 amRNSForm 8.5 (EPT/RI)
4th Mar 20229:40 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
3rd Mar 20229:37 amRNSForm 8.3 - Sensyne Health Plc
3rd Mar 20229:34 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
3rd Mar 20229:14 amRNSForm 8.5 (EPT/RI)
2nd Mar 20222:05 pmRNSSecond Price Monitoring Extn
2nd Mar 20222:00 pmRNSPrice Monitoring Extension
2nd Mar 20228:52 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
1st Mar 202210:07 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
28th Feb 20229:40 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
25th Feb 20224:00 pmRNSForm 8.5 (EPT/RI) Sensyne Health Plc - Replacement
25th Feb 20223:41 pmRNSForm 8.5 (EPT/RI) Sensyne Health Plc - Replacement
25th Feb 20229:47 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
24th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
23rd Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
23rd Feb 20228:37 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.